Quantum Materials (QTMM) 10-Q 3 Mar 17 2017 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Dec. 31, 2016	Mar. 03, 2017
Document And Entity Information
Entity Registrant Name	QUANTUM MATERIALS CORP.
Entity Central Index Key	1,403,570
Document Type	10-Q
Document Period End Date	Dec. 31, 2016
Amendment Flag	false
Current Fiscal Year End Date	--06-30
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		346,897,104
Trading Symbol	QTMM
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2,017

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2016	Jun. 30, 2016
CURRENT ASSETS
Cash and cash equivalents	$ 6,821	$ 266,985
Accounts receivable		8,835
Prepaid expenses and other current assets	44,286	102,100
TOTAL CURRENT ASSETS	51,107	377,920
PROPERTY AND EQUIPMENT, net of accumulated depreciation of $197,094 and $150,142	760,593	774,674
LICENSES AND PATENTS, net of accumulated amortization of $94,530 and $75,256	98,213	117,487
TOTAL ASSETS	909,913	1,270,081
CURRENT LIABILITIES
Accounts payable and accrued expenses	1,518,209	617,292
Accrued salaries	362,100	238,182
Notes payable, net of unamortized discount	7,818	10,093
Current portion of convertible debentures, net of unamortized discount	85,042	407,702
TOTAL CURRENT LIABILITIES	1,973,169	1,273,269
CONVERTIBLE DEBENTURES, net of current portion, unamortized discount and debt issuance costs	1,914,418	1,039,656
TOTAL LIABILITIES	3,887,587	2,312,925
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' DEFICIT
Common stock, $.001 par value, authorized 400,000,000 shares, 337,105,438 and 324,563,789 issued and outstanding at December 31, 2016 and June 30, 2016, respectively	337,105	324,564
Additional paid-in capital	30,252,621	28,415,843
Accumulated deficit	(33,567,400)	(29,783,251)
TOTAL STOCKHOLDERS' DEFICIT	(2,977,674)	(1,042,844)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 909,913	$ 1,270,081

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($)	Dec. 31, 2016	Jun. 30, 2016
Statement of Financial Position [Abstract]
Property and equipment, accumulated depreciation	$ 197,094	$ 150,142
Licenses and patents, accumulated amortization	$ 94,530	$ 75,256
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	400,000,000	400,000,000
Common stock, shares issued	337,105,438	324,563,789
Common stock, shares outstanding	337,105,438	324,563,789

Consolidated Statements of Oper

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Income Statement [Abstract]
REVENUES	$ 19,500		$ 24,500
OPERATING EXPENSES
General and administrative	1,825,983	2,410,431	3,013,784	3,308,325
Research and development	126,343	55,724	271,802	146,055
TOTAL OPERATING EXPENSES	1,952,326	2,466,155	3,285,586	3,454,380
LOSS FROM OPERATIONS	(1,932,826)	(2,466,155)	(3,261,086)	(3,454,380)
OTHER (INCOME) EXPENSE
Gain on settlement				(174,568)
Beneficial conversion expense	24,381		94,298
Interest expense, net	63,743	10,466	128,908	21,571
Accretion of debt discount	186,569	43,037	299,857	85,224
TOTAL OTHER (INCOME) EXPENSE	274,693	53,503	523,063	(67,773)
NET LOSS	$ (2,207,519)	$ (2,519,658)	$ (3,784,149)	$ (3,386,607)
LOSS PER COMMON SHARE
Basic	$ (0.01)	$ (0.01)	$ (0.01)	$ (0.01)
WEIGHTED AVERAGE SHARES OUTSTANDING
Basic and diluted	334,497,865	318,834,426	329,764,251	313,323,270

Consolidated Statements of Defi

Consolidated Statements of Deficiency In Stockholders' Equity (Unaudited) - 6 months ended Dec. 31, 2016 - USD ($)	Common Stock [Member]	Additional Paid In Capital [Member]	Accumulated Deficit [Member]	Total
Balances at Jun. 30, 2016	$ 324,564	$ 28,415,843	$ (29,783,251)	$ (1,042,844)
Balances, shares at Jun. 30, 2016	324,563,789
Common stock issued for services	$ 2,000	198,000		$ 175,000
Common stock issued for services, shares	2,000,000			1,750,000
Stock-based Compensation	$ 500	846,152		$ 846,652
Stock-based Compensation, shares	500,000			500,000
Beneficial conversion feature of debentures		94,298		$ 94,298
Common stock issued for debenture interest	$ 36	4,249		4,285
Common stock issued for debenture interest, shares	35,708
Common stock issued for debenture conversions	$ 1,250	148,750		150,000
Common stock issued for debenture conversions, shares	1,250,000
Allocated value of common stock issued for debenture conversion	$ 200	178,884		$ 179,084
Allocated value of common stock issued for debenture conversion, shares	200,000			200,000
Common stock issued for warrants exercised	$ 8,750	366,250		$ 375,000
Common stock issued for warrants exercised, shares	8,750,000
Share cancellations	$ (195)	195		0
Share cancellations, shares	(194,059)
Net loss			(3,784,149)	(3,784,149)
Balances at Dec. 31, 2016	$ 337,105	$ 30,252,426	$ (33,567,400)	$ (2,977,674)
Balances, shares at Dec. 31, 2016	337,105,438

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
CASH FLOWS FROM OPERATING ACTIVITIES
Net Loss	$ (3,784,149)	$ (3,386,607)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense	66,226	61,274
Amortization of debt issuance costs	31,329
Stock-based compensation	846,652	1,930,220
Beneficial conversion feature	94,298
Stock issued for services	180,464	88,715
Gain on settlement		(174,568)
Accretion of debt discount	299,857	85,224
Effects of changes in operating assets and liabilities
Accounts receivable	8,835
Prepaid expenses and other assets	75,075	179,172
Accounts payable and accrued expenses	905,202	174,758
Accrued Salaries	123,918
Deferred revenue		225,000
NET CASH USED IN OPERATING ACTIVITIES	(1,152,293)	(816,812)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property and equipment	(32,871)	(43,648)
Change in restricted cash		65,330
NET CASH (USED IN) PROVIDED BY INVESTING ACTIVITIES	(32,871)	21,682
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from warrant exercises and issuances of common stock	375,000	430,500
Issuance of convertible debentures	550,000
Issuance of promissory note	100,000
Principal payments on promissory note	(100,000)
NET CASH PROVIDED BY FINANCING ACTIVITIES	925,000	430,500
NET DECREASE IN CASH AND CASH EQUIVALENTS	(260,164)	(364,630)
CASH AND CASH EQUIVALENTS at the beginning of the year	266,985	673,839
CASH AND CASH EQUIVALENTS at the end of the period	$ 6,821	$ 309,209

Basis of Presentation

Basis of Presentation	6 Months Ended
	Dec. 31, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	NOTE 1 – BASIS OF PRESENTATION General The accompanying consolidated financial statements include the accounts of Quantum Materials Corp. and its wholly owned subsidiary, Solterra Renewable Technologies, Inc. (collectively referred to as the “Company”). The consolidated financial statements of the Company as of and for the six months ended December 31, 2016 are unaudited and have been prepared on the same basis as the audited consolidated financial statements as of and for the year ended June 30, 2016. The year-end balance sheet data was derived from audited consolidated financial statements, but does not include all disclosures required by accounting principles generally accepted in the U.S. In the opinion of management, the accompanying unaudited financial information includes all adjustments necessary for a fair presentation of the interim financial information. Operating results for the interim periods are not necessarily indicative of the results of any subsequent periods. Certain information in the footnote disclosures normally included in annual consolidated financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) has been condensed or omitted for the interim periods presented under the United States Securities and Exchange Commission (“SEC”) rules and regulations. As such, these interim consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the year ended June 30, 2016. Nature of Operations The Company is a nanotechnology company specializing in the design, development, production and supply of quantum dots, including tetrapod quantum dots, a high performance variant of quantum dots, and highly uniform nanoparticles, using its patented automated continuous flow production process. Quantum dots and other nanoparticles are expected to be increasingly utilized in a range of applications in the life sciences, television and display, solid state lighting, solar energy, battery, security ink, and sensor sectors of the market. Key uncertainties and risks to the Company include, but are not limited to, if and how quickly various industries adopt and fully embrace quantum dot technology and technological changes, including those developed by the Company’s competitors, rendering the Company’s technology uncompetitive or obsolete. Going Concern The Company recorded losses from continuing operations in the current period presented and has a history of losses. The ability of the Company to continue as a going concern is dependent upon its ability to reverse negative operating trends, obtain revenues from operations, raise additional capital, and/or obtain debt financing. In conjunction with anticipated revenue streams, management is currently negotiating equity and debt financing, the proceeds from which would be used to settle outstanding debts, to finance operations, and for general corporate purposes. However, there can be no assurance that the Company will be able to raise capital, obtain debt financing, or improve operating results sufficiently to continue as a going concern. The accompanying unaudited consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classification of liabilities that might be necessary if the Company is unable to continue as a going concern.

Property and Equipment

Property and Equipment	6 Months Ended
	Dec. 31, 2016
Property, Plant and Equipment [Abstract]
Property and Equipment	NOTE 2 – PROPERTY AND EQUIPMENT Property and equipment consisted of the following: December 31, 2016 June 30, 2016 (unaudited) Furniture and fixtures $ 1,625 $ 1,625 Computers and software 11,447 11,447 Machinery and equipment 944,615 911,744 957,687 924,816 Less: accumulated depreciation 197,094 150,142 Total property and equipment, net $ 760,593 $ 774,674 Depreciation expense for the three months ended December 31, 2016 and 2015 was $23,937 and $21,591, respectively, and $46,952 and $42,000 for the six months ended December 31, 2016 and 2015, respectively.

Licenses and Patents

Licenses and Patents	6 Months Ended
	Dec. 31, 2016
Finite-Lived Intangible Assets, Net [Abstract]
Licenses and Patents	NOTE 3 – LICENSES AND PATENTS Licenses and patents consisted of the following: December 31, 2016 June 30, 2016 (unaudited) William Marsh Rice University $ 40,000 $ 40,000 University of Arizona 15,000 15,000 Bayer acquired patents 137,743 137,743 192,743 192,743 Less: accumulated amortization 94,530 75,256 Total licenses and patents, net $ 98,213 $ 117,487 Amortization expense for the three months ended December 31, 2016 and 2015 was $9,637 and $9,637, respectively, and $19,274 and $19,274 for the six months ending December 31, 2016 and 2015, respectively.

Fair Value of Financial Instrum

Fair Value of Financial Instruments	6 Months Ended
	Dec. 31, 2016
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Fair Value of Financial Instruments	NOTE 4 – FAIR VALUE OF FINANCIAL INSTRUMENTS The Company follows Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) 2011-04 “Fair Value Measurement” This guidance defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Hierarchical levels, as defined in this guidance and directly related to the amount of subjectivity associated with the inputs to fair valuations of these assets and liabilities are as follows: Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means. Level 3 – Inputs that are both significant to the fair value measurement and unobservable. The reported fair values for financial instruments that use Level 2 and Level 3 inputs to determine fair value are based on a variety of factors and assumptions. Accordingly, certain fair values may not represent actual values of the financial instruments that could have been realized as of December 31, 2016 and June 30, 2016 or that will be realized in the future and do not include expenses that could be incurred in an actual sale or settlement. The carrying amounts of cash and cash equivalents, accounts payable and current debt approximate their fair value due to the short maturity of those instruments. Convertible Debentures The Company measured the estimated fair value of the convertible debentures using significant other observable inputs, representative of a Level 2 fair value measurement, including the interest and conversion rates for the instruments. The following table sets forth the fair value of the Company’s convertible debentures as of December 31, 2016, and June 30, 2016: December 31, 2016 June 30, 2016 (unaudited) Carrying Fair Carrying Fair Amount Value Amount Value Convertible debentures issued in September 2014 $ 25,050 $ 22,525 $ 25,050 $ 21,710 Convertible debentures issued in January 2015 $ 500,000 $ 750,000 $ 500,000 $ 1,083,333 Convertible debentures issued in April - June 2016 $ 1,465,000 $ 1,220,834 $ 1,565,000 $ 1,695,417 Convertible debenture issued in August 2016 $ 200,000 $ 177,031 $ - $ - Convertible debenture issued in September 2016 $ 100,000 $ 88,650 $ - $ - Convertible debenture issued in November 2016 $ 200,000 $ 177,031 $ - $ - The Company is not a party to any hedge arrangements or commodity swap agreements.

Convertible Debentures

Convertible Debentures	6 Months Ended
	Dec. 31, 2016
Debt Disclosure [Abstract]
Convertible Debentures	NOTE 5 – CONVERTIBLE DEBENTURES The following table sets forth activity associated with the convertible debentures: December 31, 2016 June 30, 2016 (unaudited) Convertible debentures issued in September 2014 $ 25,050 $ 25,050 Convertible debentures issued in January 2015 500,000 500,000 Convertible debentures issued in April - June 2016 1,565,000 1,565,000 Convertible debenture issued in August 2016 200,000 - Convertible debenture issued in September 2016 100,000 - Convertible debenture issued in October 2016 50,000 - Convertible debenture issued in November 2016 200,000 - 2,640,050 2,090,050 Less: amount converted to shares (150,000 ) - Total convertible debentures outstanding 2,490,050 2,090,050 Less: unamortized discount 406,577 527,350 Less: debt issuance costs 84,013 115,342 1,999,460 1,447,358 Less: current portion 85,042 407,702 Total convertible debentures, net of current portion $ 1,914,418 $ 1,039,656 September 2014 Convertible Debenture Between September 16, 2014 and October 28, 2014, the Company entered into Convertible Debenture Agreements to obtain a total of $500,050 in gross proceeds from five non-affiliated parties (collectively hereinafter referred to as the “Debenture Holders”). The Debentures have terms of five years maturing between September 16, 2019 and October 30, 2019. The Debentures bear interest at the rate of 6% per annum and are pre-payable by the Company at any time without penalty. The Debenture Holders have the right of conversion into unregistered and restricted shares of Common Stock at a conversion price of $0.15 per share at any date, and will receive an equal number of warrants having a strike price of $0.30 per share and a term of five years. Interest expense for the three months ended December 31, 2016 and 2015 was $384 and $384, respectively. Interest expense for the six months ended December 31, 2016 was $768 and $768 in the comparable period in 2015. As of December 31, 2016, $25,050 of principal was outstanding. January 2015 Convertible Debenture On January 15, 2015, the Company entered into Convertible Debenture Agreements to obtain $500,000 in gross proceeds from two non-affiliated parties (collectively hereinafter referred to as the “Debenture Holders”). The Debentures have a term of two years maturing on January 15, 2017 and bear interest at the rate of 8% per annum. The debentures are pre-payable by the Company at any time without penalty. The Debenture Holders have the right of conversion into unregistered and restricted shares of Common Stock at a conversion price of $0.06 per share at any date. The Debenture Holders received 6,250,000 common stock warrants exercisable at $0.06 per share through January 15 2017. The debt is secured by a security interest in certain microreactor equipment. The Agreement also provides for the investors to have the right to appoint one member to the Company’s Board of Directors in the event that any one of the aforementioned debentures are converted into common stock of the Company. On October 10 2016 the maturity date of the debentures was extended to January 15, 2018 and were reclassified as non-current on the consolidated balance sheet. The 6,250,000 warrants were converted into common stock for total proceeds of $375,000 in January 2017. In accounting for the convertible debentures, the Company allocated the fair value of the warrants to the proceeds received in the amount of $348,105, recorded as debt discount and is amortized using the effective interest rate method over the life of the loan, two years. The Company recognized accretion of debt discount expense for the three months ended December 31, 2016 and 2015 of $46,609 and $43,037, respectively, and for the six months ended December 31, 2016 and 2015 the accretion expense was $92,298 and $85,224, respectively. Interest expense for the three months ended December 31, 2016 and 2015 was $10,082 and $10,082, respectively, and for the six months ended December 31, 2016 and 2015 was $20,164 and $20,164, respectively. As of December 31, 2016, $500,000 of principal was outstanding. April – June, August and October 2016 Convertible Debentures During the fourth quarter of the year ended June 30, 2016, the Company sold 1,565 Units for total proceeds of $1,565,000 from three affiliated and fourteen non-affiliated parties. In August 2016 the Company sold 200 additional Units for total proceeds of $200,000, and sold $50,000 in proceeds in October 2016. Each Unit consists of a $1,000 Unsecured Convertible Promissory Note (each, a “Note”) and a warrant to purchase 4,166 shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”) at a purchase price of $0.15 per share (each, a “Warrant”) over a period of five years. The Notes which were issued at face value have a maturity of two years from the date of issuance, bear interest at the rate of 8% per annum and are convertible into unregistered and restricted shares of Common Stock at $0.12 per-share, subject to normal and customary adjustments including (a) any subdivisions, combinations and classifications of the Common Stock; or (b) any payment, issuance or distribution by the Company to its stockholders of (i) a stock dividend, (ii) debt securities of the Company, or (iii) assets (other than cash dividends payable out of earnings or surplus in the ordinary course of business). The conversion price also is subject to a full ratchet adjustment upon the Company’s issuance of Common Stock, warrants, or rights to purchase Common Stock or securities convertible into Common Stock for a consideration per share which is less than the then applicable conversion price of the Notes excluding Common Stock and options issued to officers, directors, and employees of the Company, except for the exercise or conversion of existing convertible securities of the Company. In evaluating the accounting treatment of this anti-dilution feature, the Company believes that is has control over whether or not the anti-dilution feature will be exercised. The Company is able to decide on which type of financing is raised, and thus the Company can prevent the issuance of shares at a price below the anti-dilution strike price. The number of Warrants and exercise price is proportionately adjustable for events including subdivisions, combinations or consolidations, reclassifications, exchanges, mergers, and reorganizations. In accounting for the convertible debentures, the Company allocated the fair value of the warrants to the proceeds received in the amount of $566,778, recorded as debt discount and is amortized using the effective interest rate method over the life of the loan, two years. The Company recognized accretion of debt discount expense for the three months ended December 31, 2016 and 2015 of $100,349 and $0, respectively and $162,454 and $0 for the six months ending December 31, 2016 and 2015, respectively. The Company recognized a beneficial conversion expense for the three months ended December 31, 2016 and 2015 of $4,897 and $0, respectively, and $45,291 and $0 for the six months ended December 31, 2016 and 2015, respectively. Interest expense for the three months ended December 31, 2016 and 2015 of $35,105 and $0, respectively, and $68,789 and $0 for the six months ending December 31, 2016 and 2015, respectively. As of December 31, 2016, $1,665,000 of principal was outstanding after conversion of $150,000 of debentures into common stock. September 2016 Convertible Promissory Note In September 2016, the Company entered into a Securities Purchase Agreement and Convertible Promissory Note to obtain $100,000 in gross proceeds from a non-affiliated party (collectively hereinafter referred to as the “Note Holder”) in exchange for 200,000 unregistered and restricted shares of common stock of the Company and a convertible promissory note in the principal amount of $100,000. The Note Holder received 250,000 common stock warrants exercisable at $0.12 per share through September 15, 2019. The promissory note has a term of eight months maturing on May 15, 2017 and stipulates a one-time interest charge of eight percent (8%) shall be applied on the issuance date to the principal. The promissory note is pre-payable by the Company at any time without penalty. The Note Holder has the right of conversion into unregistered and restricted shares of Common Stock at a conversion price of $0.12 per share at any date. The promissory note includes piggyback registration rights and the Company shall include on the next registration statement it files with the SEC all shares issuable upon conversion of the note. In accounting for the convertible promissory note, the Company allocated the fair value of the common stock and warrants to the proceeds received in the amount of $29,523, recorded as debt discount and is amortized using the effective interest rate method over the life of the loan, eight months. The Company recognized accretion of debt discount expense for the three months ended December 31, 2016 and 2015 of $10,959 and $0, respectively, and $14,564 and $0 for the six months ending December 31, 2016 and 2015, respectively. The Company recognized a beneficial conversion expense for the three months ended December 31, 2016 and 2015 of $0 and $0, respectively, and $29,523 and $0 for the six months ending December 31, 2016 and 2015, respectively. Interest expense for the three months ended December 31, 2016 and 2015 were $3,653 and $0, respectively. Interest expense for the six months ended December 31, 2016 was $7,258 and $0 respectively. As of December 31, 2016, $100,000 of principal was outstanding. November 2016 Convertible Promissory Notes In November 2016, the Company entered into a Securities Purchase Agreement and Convertible Promissory Note to obtain $200,000 in gross proceeds from a non-affiliated party (collectively hereinafter referred to as the “Note Holder”) in the principal amount of $200,000. The promissory note has a term of twenty-four months maturing on November 7, 2017 and stipulates a one-time interest charge of eight percent (8%) shall be applied on the issuance date to the principal. The promissory note is pre-payable by the Company at any time without penalty. The Note Holder has the right of conversion into unregistered and restricted shares of Common Stock at a conversion price of $0.12 per share at any date. In accounting for the convertible promissory note, the Company allocated the fair value of the common stock and warrants to the proceeds received in the amount of $52,817, recorded as debt discount and is amortized using the effective interest rate method over the life of the loan, twenty four months. The Company recognized accretion of debt discount expense for the three months and six months ended December, 2016 and 2015 of $4,807 and $0, respectively. The Company recognized a beneficial conversion expense for the three months and six months ended December 31, 2016 and 2015 of $19,484 and $0, respectively. The Company recognized interest expense for the three months ended and six months ending December 31, 2016 and 2015 of $2,400 and $0, respectively. As of December 31, 2016, $200,000 of principal was outstanding. Debt Issuance Costs The costs related to the issuance of debt are presented on the balance sheet as a direct deduction from the related debt and amortized to interest expense using the effective interest method over the maturity period of the related debt. Amortization expense for the three months ended December 31, 2016 and 2015 was $15,821 and $0, respectively, and $31,329 and $0 for the six months ending December 31, 2016 in 2015, respectively.

Notes Payable

Notes Payable	6 Months Ended
	Dec. 31, 2016
Debt Disclosure [Abstract]
Notes Payable	NOTE 6 – NOTES PAYABLE Promissory Note In September 2016 the Company issued an unsecured promissory note for proceeds of $100,000. The note bears 0% interest and the Company issued 416,667 common stock warrants exercisable at $0.15 per share through September 29, 2021. The note was due October 13, 2016 and was repaid on October 11, 2016. In accounting for the promissory note, the Company allocated the fair value of the warrants to the proceeds received in the amount of $26,454, recorded as debt discount and is amortized using the effective interest rate method over the life of the loan, fourteen days. The Company recognized accretion of debt discount expense for the three months ended December 31, 2016 and 2015 of $24,564 and $0, respectively. For the six months ended December 31, 2016 and 2015 the accretion of debt discount was $26,454 and $0 respectively. As of December 31, 2016, $0 of principal was outstanding. See Note 13 for additional information. Note Payable – Insurance In August 2016, to finance an insurance premium, the Company issued a negotiable promissory note for $13,959 at an interest rate of 4.87% per annum. The note is due May 5, 2017. The balance outstanding at December 31, 2016 was $7,818.

Equity Transactions

Equity Transactions	6 Months Ended
	Dec. 31, 2016
Equity [Abstract]
Equity Transactions	NOTE 7 – EQUITY TRANSACTIONS Common Stock During the six months ended December 31, 2016, the Company granted 250,000 shares of common stock to consultants at the fair market value of $25,000. This was recognized as a prepaid asset and will be amortized to expense over the life of the agreement. During the six months ended December 31, 2016, the Company issued 1,750,000 shares for consulting services valued at $175,000. During the six months ended December 31, 2016, the Company issued 35,708 shares of common stock at the fair market value of $4,285 for payment of debenture interest. During the six months ended December 31, 2016, the Company issued 1,250,000 shares of common stock at the fair market value of $150,000 as a result of debenture conversions. During the six months ended December 31, 2016, the Company issued 200,000 shares in connection with the issuance of the September 2016 promissory note. During the six months ending December 31, 2016, the Company issued 8,750,000 shares of common stock for warrants exercised, including 2,500,000 shares issued in connection with cashless exercises. During the six months ending December 31, 2016, the Company cancelled 194,059 common shares. Stock Warrants A summary of activity of the Company’s stock warrants for the six months ended December 31, 2016 is presented below: Weighted Weighted Average Weighted Average Remaining Average Exercise Number of Contractual Grant Date Price Warrants Term in Years Fair Value Balance as of June 30, 2016 $ 0.11 39,262,305 $ 0.15 Expired 0.18 (555,555 ) 0.14 Granted 0.17 4,458,034 0.09 Exercised 0.06 (11,250,000 ) 0.15 Cancelled - - - Balance as of December 31, 2016 $ 0.13 31,914,784 2.76 $ 0.14 Vested and exercisable as of December 31, 2016 $ 0.13 31,914,784 2.76 $ 0.14 Outstanding warrants at December 31, 2016 expire during the period January 2017 to November 2021 and have exercise prices ranging from $0.04 to $0.30.

Stock-Based Compensation

Stock-Based Compensation	6 Months Ended
	Dec. 31, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock-Based Compensation	NOTE 8 – STOCK-BASED COMPENSATION The Company follows FASB Accounting Standards Codification (“ASC”) 718 “Compensation — Stock Compensation” In October 2009 the Board of Directors authorized the approval of a stock option plan covering 7,500,000 shares of common stock, which was increased to 10,000,000 shares in December 2009 and approved by stockholders in January 2010. The Plan provides for the direct issuance of common stock and the grant of incentive and non-incentive stock options. As of December 31, 2016, 9,200,000 options have been granted, with terms ranging from five to ten years, and 250,000 have been cancelled. In March 2012, 3,500,000 stock options, with a term of five years, were granted outside of a stock option plan. In January 2013 the Board of Directors authorized the approval of a stock option plan covering 20,000,000 shares of common stock, which was increased to 60,000,000 shares in March 2013 and approved by stockholders in March 2013. The Plan provides for the direct issuance of common stock and the grant of incentive and non-incentive stock options. As of December 31, 2016, 72,653,473 options have been granted, with terms ranging from five to ten years, 3,325,000 have been exercised and 12,803,225 have been cancelled. On February 17, 2016, the Shareholders approved the 2015 Employee Benefit and Consulting Services Compensation Plan covering 15,000,000 shares. The Plan provides for the direct issuance of common stock and the grant of incentive and non-incentive stock options. As of December 31, 2016, 2,800,000 options have been granted with a term of five years. In June 2016 6,000,000 stock options, with a term of ten years, were granted outside of a stock option plan, and 3,000,000 shares were cancelled. Incentive Stock Options: The following assumptions were used for the periods indicated: Six Months Ended December 31, 2016 2015 Expected volatility 140.73 % 147.62 % Expected dividend yield - - Risk-free interest rates 1.25 % 1.49 % Expected term (in years) 5.0 5.0 The computation of expected volatility during the six months ended December 31, 2016 and 2015 was based on the historical volatility. Historical volatility was calculated from historical data for the time approximately equal to the expected term of the option award starting from the grant date. The risk-free interest rate assumption is based upon the U.S. Treasury yield curve in effect at the time of grant for the period corresponding with the expected life of the option. A summary of the activity of the Company’s stock options for the six months ended December 31, 2016 is presented below: Weighted Weighted Weighted Average Average Average Number of Remaining Optioned Aggregate Exercise Optioned Contractual Grant Date Intrinsic Price Shares Term in Years Fair Value Value Balance as of June 30, 2016 $ 0.08 75,375,248 $ 0.11 $ 3,771,601 Expired - - - Granted 0.12 2,500,000 0.10 Exercised - - - Cancelled 0.13 (3,100,000 ) - Balance as of December 31, 2016 $ 0.08 74,775,248 5.11 $ 0.11 $ 734,591 Vested and exercisable as of December 31, 2016 $ 0.07 64,908,580 4.45 $ 0.11 $ 1,095,591 Outstanding options at December 31, 2016 expire during the period March 2017 to June 2026 and have exercise prices ranging from $0.04 to $0.17. Compensation expense associated with stock options for the three months ended December 31, 2016 and 2015 was $568,599 and $1,162,431, respectively, and $740,789 and $1,340,905 for the six months ended December 31, 2016 and 2015, respectively, and was included in general and administrative expenses in the consolidated statements of operations. At December 31, 2016, the Company had 9,866,668 shares of nonvested stock option awards. The total cost of nonvested stock option awards which the Company had not yet recognized was $721,253 at December 31, 2016. Such amounts are expected to be recognized over a period of 2.75 years. Restricted Stock: Number of Nonvested, Weighted Non-issued Average Restricted Grant Date Share Awards Fair Value Nonvested, nonissued restricted shares outstanding at June 30, 2016 1,000,000 $ 0.42 Granted - - Vested (500,000 ) 0.42 Forfeited - - Nonvested, nonissued restricted shares outstanding at December 31, 2016 500,000 $ 0.42 Compensation expense associated with restricted stock for the three months ended December 31, 2016 and 2015 was $52,931 and $87,932, respectively, and $105,863 and $140,863 for the six months ended December 31, 2016 and 2015, respectively, and was included in general and administrative expenses in the consolidated statements of operations. The total cost of nonvested stock awards which the Company had not yet recognized was $112,192 at December 31, 2016. This amount is expected to be recognized over a period of 1 year. Agreements with Officers and Employees:

Loss Per Share

Loss Per Share	6 Months Ended
	Dec. 31, 2016
LOSS PER COMMON SHARE
Loss Per Share	NOTE 9 – LOSS PER SHARE The Company follows ASC 260, “Earnings Per Share”, The following table sets forth the computation of basic and diluted loss per share: Three Months Ended Six Months Ended December 31, December 31, 2016 2015 2016 2015 (unaudited) Net loss $ (2,207,519 ) $ (2,519,658 ) $ (3,784,149 ) $ (3,386,607) Weighted average common shares outstanding: Basic and diluted 334,497,865 318,834,426 329,764,251 313,323,270 Basic and diluted loss per share $ (0.01 ) $ (0.01 ) $ (0.01 ) $ (0.01 ) For the three months and six months ended December 31, 2016 and 2015, 31,914,784 and 36,994,557 stock warrants, respectively, were excluded from diluted earnings per share because they are considered anti-dilutive. For the three months and six months ended December 31, 2016 and 2015, 74,775,248 and 62,625,248 stock options, respectively, were excluded from diluted earnings per share because they are considered anti-dilutive.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Dec. 31, 2016
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	NOTE 10 - COMMITMENTS AND CONTINGENCIES Agreement with Rice University On August 20, 2008, Solterra entered into a License Agreement with Rice University, which was amended and restated on September 26, 2011; also on September 26, 2011, QMC entered into a new License Agreement with Rice (collectively the “Rice License Agreements”). On August 21, 2013, QMC and Solterra each entered into amended license agreements with Rice University. QMC and Solterra entered into second amended license agreements with Rice University on March 15 and 24, 2016, respectively. The Rice License Agreements, as amended, require the payment of certain patent fees to Rice and for QMC and Solterra to meet certain milestones by specific dates. Pursuant to the Solterra Rice License Agreement, as amended, Rice is entitled to receive, during the term, certain royalties of adjusted gross sales (as defined therein) ranging from 2% to 4% for photovoltaic cells and 7.5% of adjusted gross sales for QDs sold in electronic and medical applications. Additionally, minimum royalties payable under the Solterra Rice License Agreement include $100,000 due January 1, 2017, $356,250 due January 1, 2018, $1,453,500 due January 1, 2019, $3,153,600 due January 1, 2020 and each January 1 of every year thereafter, subject to adjustments for changes in the consumer pricing index. Such minimum royalty payments shall be credited against royalties due in each respective royalty year, January 1 to December 31, following the due date. Pursuant to the QMC Rice License Agreement, as amended, Rice is entitled to receive, during the term, a royalty of 7.5% of adjusted gross sales for QDs sold in electronic and medical applications. Additionally, minimum royalties payable under the QMC Rice License Agreement include $117,000 due January 1, 2017, $292,500 due January 1, 2018, $585,000 due January 1, 2019 and each January 1 of every year thereafter, subject to adjustments for changes in the consumer pricing index. Such minimum royalty payments shall be credited against royalties due in each respective royalty year, January 1 to December 31, following the due date. The Rice License Agreements and subsequent amendments have been filed on Form 8-K and are incorporated by reference herein. The Company is in the process of renegotiating the minimum royalty commitments and while oral modifications have been agreed to a final amendment has not been finalized. Agreement with University of Arizona Solterra entered into an exclusive Patent License Agreement with the University of Arizona (“UA”) in July 2009. On June 8, 2016, Solterra entered into an amended license agreement with UA. Pursuant to UA License Agreement, as amended, Solterra is obligated to pay minimum annual royalties of $50,000 by December 31, 2016, $125,000 by June 30, 2017 and $200,000 on each June 30th thereafter, subject to adjustments for increases in the consumer price index. Such minimum royalty payments shall be credited against royalties due in each respective royalty year, July 1 to June 30, following the due date. Royalties based on net sales are 2% of net sales of licensed products for non-display electronic component applications and 2.5% of net sales of licensed products for printed electronic displays. The UA License Agreements and subsequent amendments have been filed on Form 8-K and are incorporated by reference herein. The Company is in the process of renegotiating the minimum royalty commitments and while oral modifications have been agreed to a final amendment has not been finalized. Agreement with Texas State University The Company entered into a Service Agreement with Texas State University (“TSU”) by which the Company occupies certain office and lab space at TSU’s STAR Park (Science Technology and Advanced Research) Facility. The agreement is month-to-month and can be terminated with 30-days written notice of either party.

Income Tax

Income Tax	6 Months Ended
	Dec. 31, 2016
Income Tax Disclosure [Abstract]
Income Tax	NOTE 11 – INCOME TAX The Company follows ASC 740 “Income Taxes” The Company assesses the likelihood that deferred tax assets will be recovered from the existing deferred tax liabilities or future taxable income. To the extent the Company believes that recovery will not meet the more likely than not threshold, it establishes a valuation allowance. The Company has recorded valuation allowances in the U.S. for its net deferred tax assets since management believes it is more likely than not that these assets will not be realized because future taxable income necessary to utilize these losses cannot be established or projected. The Company had approximately $25,560,000 in U.S. net operating loss (“NOL”) carryforwards that expire beginning in 2029 as of its fiscal year ending June 30, 2016, and $28,230,000 in NOL’s available as of December 31, 2016 prior to any reductions under Section 382 of the Internal Revenue Code of 1986, as amended (“IRC Section 382”). Section 382 provides that a corporation that undergoes an “ownership change”, as defined therein, is subject to limitations on its use of pre-change NOL carryforwards to offset future taxable income. The Company completed an evaluation study whether an “ownership change” had occurred and determined that the limitation would be approximately $750,000, thereby reducing the net operating loss at December 31, 2016 to approximately $27,480,000. The Company has recorded a valuation allowance on the entire NOL as it believes that it is more likely than not that all of the deferred tax asset associated with the NOLs will not be realized regardless of whether an “ownership change” has occurred. When a company operates in a jurisdiction that generates ordinary losses but does not expect to realize them, ASC 740-270-30-36(a) requires the exclusion of the respective jurisdiction from the overall annual effective tax rate (“AETR”) calculation and instead, a separate AETR should be computed. The Company operates in one jurisdiction and has determined that its deferred tax assets are not realizable on a more likely than not basis and has recorded a full valuation allowance. The effective income tax rate for the three months and six ended December 31, 2016 and 2015 was 0%.

Supplemental Cash Flow Informat

Supplemental Cash Flow Information	6 Months Ended
	Dec. 31, 2016
Supplemental Cash Flow Elements [Abstract]
Supplemental Cash Flow Information	NOTE 12 – SUPPLEMENTAL CASH FLOW INFORMATION The following is supplemental cash flow information: Six Months Ended December 31 2016 2015 (unaudited) Cash paid for interest $ 292 $ 20,055 Cash paid for income taxes $ - $ - The following is supplemental disclosure of non-cash investing and financing activities: Six Months Ended December 31, 2016 2015 (unaudited) Allocated value of common stock and warrants issued with convertible debentures and promissory notes $ 179,084 $ - Prepaid expense paid in shares of common stock $ 19,536 $ 161,285 Financing of prepaid insurance $ 7,407 $ - Stock warrants issued for conversion of accrued salaries $ - $ 409,667 Cancellation of shares $ 195 $ - Stock issued for interest payments $ 4,284 $ - Conversion of debentures into common stock $ 150,000 $ -

Transactions with Affiliated Pa

Transactions with Affiliated Parties	6 Months Ended
	Dec. 31, 2016
Related Party Transactions [Abstract]
Transactions with Affiliated Parties	NOTE 13 – TRANSACTIONS WITH AFFILIATED PARTIES During the six months ended December 31, 2016, the Company issued a convertible debenture to a family member of a key executive for proceeds of $200,000. This transaction is described in more detail in Note 5 under the heading April – June, August and October 2016 Convertible Debentures. In September 2016, the Company’s Chief Financial Officer loaned the Company $100,000 to provide short-term bridge financing. This transaction is described in more detail in Note 6 under the heading “Promissory Note”. The Company repaid the loan on October 11, 2016.

Recently Issued Accounting Stan

Recently Issued Accounting Standards	6 Months Ended
	Dec. 31, 2016
Accounting Changes and Error Corrections [Abstract]
Recently Issued Accounting Standards	NOTE 14 – RECENTLY ISSUED ACCOUNTING STANDARDS In March 2016, the FASB issued ASU 2016-09, Compensation – Stock Compensation: Improvements to Employee Share-Based Payment Accounting. In February 2016, the FASB issued ASU 2016-02, Leases, In November 2015, the FASB issued ASU 2015-17, Income Taxes: Balance Sheet Classification of Deferred Taxes. In August 2014, the FASB issued ASU No. 2014-15 Preparation of Financial Statements — Going Concern (Subtopic 205-40), Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers Revenue from Contracts with Customers: Deferral of the Effective Date, Revenue from Contracts with Customers: Identifying Performance Obligations and Licensing.

Subsequent Events

Subsequent Events	6 Months Ended
	Dec. 31, 2016
Subsequent Events [Abstract]
Subsequent Events	NOTE 15 - SUBSEQUENT EVENTS On January 12, 2017, the Company issued a total of $110,000 in unsecured convertible promissory notes and 458,260 warrants to purchase common shares of the Company at a purchase price of $0.15 per share. On January 17, 2017, the Company issued 1,000,000 common shares to San Diego Torrey Hills Capital, Inc. at a value of $70,000 for financial services to be rendered for the twelve months ending December 31, 2017. On January 30, 2017, our joint venture partner, The Guanghui Technology Group (“GTG”) and Quantum Materials Asia Co., Ltd. (“QMA”) agreed to an investment by the China Government Guidance Fund of $21.8 million US dollars in GTG and QMA. Quantum owns a 25% interest in QMA. Quantum has the right to 50% of the profit distributions from QMA. Quantum also manages QMA and has 50% of the board membership in QMA. The QMA joint venture will be registered in Hong Kong. The investment by China Government Guidance Fund described above in GTG and QMA together with Quantum Materials patented mass-productions quantum dot manufacturing technology will enable QMA to start supplying quantum dots to clients in the display, lighting and solar industries. On February 1, 2017, Quantum Materials Corp. and Craig Lindberg entered into a Resignation Agreement pursuant to which Mr. Lindberg’s resigned as Chief Financial Officer. In accordance with the Resignation Agreement, Quantum agreed to recognize fully vested stock options and warrants totaling 11,729,157 shares. Quantum also agreed to reimburse Mr. Lindberg and to make payment of unpaid wages of $10,000 through December 31, 2016, $20,000 for January and February, 2017, and $14,543 in expenses. On February 1, 2017, the Board of Directors of Quantum elected E. Jamie Schloss as Chief Financial Officer. Mr. Schloss does not have an employment agreement at this time and he is an employee at will. He will receive an initial salary of $4,600 per month (inclusive of certain expenses). Quantum and Mr. Schloss have agreed to re-evaluate his initial base salary after a period of three months. In February, 2017, the Company issued 1,466,666 common shares pursuant to a line of credit agreement allowing for borrowing of up to $500,000 and 200,000 common shares pursuant to a Securities Purchase Agreement. In February, 2017, the Company issued 5,125,000 common shares pursuant to two consulting agreements. In February, 2017, the Company issued 2,000,000 common shares pursuant to a consulting agreement.

Basis of Presentation (Policies

Basis of Presentation (Policies)	6 Months Ended
	Dec. 31, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
General	General The accompanying consolidated financial statements include the accounts of Quantum Materials Corp. and its wholly owned subsidiary, Solterra Renewable Technologies, Inc. (collectively referred to as the “Company”). The consolidated financial statements of the Company as of and for the six months ended December 31, 2016 are unaudited and have been prepared on the same basis as the audited consolidated financial statements as of and for the year ended June 30, 2016. The year-end balance sheet data was derived from audited consolidated financial statements, but does not include all disclosures required by accounting principles generally accepted in the U.S. In the opinion of management, the accompanying unaudited financial information includes all adjustments necessary for a fair presentation of the interim financial information. Operating results for the interim periods are not necessarily indicative of the results of any subsequent periods. Certain information in the footnote disclosures normally included in annual consolidated financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) has been condensed or omitted for the interim periods presented under the United States Securities and Exchange Commission (“SEC”) rules and regulations. As such, these interim consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the year ended June 30, 2016.
Nature of Operations	Nature of Operations The Company is a nanotechnology company specializing in the design, development, production and supply of quantum dots, including tetrapod quantum dots, a high performance variant of quantum dots, and highly uniform nanoparticles, using its patented automated continuous flow production process. Quantum dots and other nanoparticles are expected to be increasingly utilized in a range of applications in the life sciences, television and display, solid state lighting, solar energy, battery, security ink, and sensor sectors of the market. Key uncertainties and risks to the Company include, but are not limited to, if and how quickly various industries adopt and fully embrace quantum dot technology and technological changes, including those developed by the Company’s competitors, rendering the Company’s technology uncompetitive or obsolete.
Going Concern	Going Concern The Company recorded losses from continuing operations in the current period presented and has a history of losses. The ability of the Company to continue as a going concern is dependent upon its ability to reverse negative operating trends, obtain revenues from operations, raise additional capital, and/or obtain debt financing. In conjunction with anticipated revenue streams, management is currently negotiating equity and debt financing, the proceeds from which would be used to settle outstanding debts, to finance operations, and for general corporate purposes. However, there can be no assurance that the Company will be able to raise capital, obtain debt financing, or improve operating results sufficiently to continue as a going concern. The accompanying unaudited consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classification of liabilities that might be necessary if the Company is unable to continue as a going concern.

Property and Equipment (Tables)

Property and Equipment (Tables)	6 Months Ended
	Dec. 31, 2016
Property, Plant and Equipment [Abstract]
Schedule of Property and Equipment	Property and equipment consisted of the following: December 31, 2016 June 30, 2016 (unaudited) Furniture and fixtures $ 1,625 $ 1,625 Computers and software 11,447 11,447 Machinery and equipment 944,615 911,744 957,687 924,816 Less: accumulated depreciation 197,094 150,142 Total property and equipment, net $ 760,593 $ 774,674

Licenses and Patents (Tables)

Licenses and Patents (Tables)	6 Months Ended
	Dec. 31, 2016
Finite-Lived Intangible Assets, Net [Abstract]
Schedule of Licenses and Patents	Licenses and patents consisted of the following: December 31, 2016 June 30, 2016 (unaudited) William Marsh Rice University $ 40,000 $ 40,000 University of Arizona 15,000 15,000 Bayer acquired patents 137,743 137,743 192,743 192,743 Less: accumulated amortization 94,530 75,256 Total licenses and patents, net $ 98,213 $ 117,487

Fair Value of Financial Instr25

Fair Value of Financial Instruments (Tables)	6 Months Ended
	Dec. 31, 2016
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Fair Value of Convertible Debentures	The following table sets forth the fair value of the Company’s convertible debentures as of December 31, 2016, and June 30, 2016: December 31, 2016 June 30, 2016 (unaudited) Carrying Fair Carrying Fair Amount Value Amount Value Convertible debentures issued in September 2014 $ 25,050 $ 22,525 $ 25,050 $ 21,710 Convertible debentures issued in January 2015 $ 500,000 $ 750,000 $ 500,000 $ 1,083,333 Convertible debentures issued in April - June 2016 $ 1,465,000 $ 1,220,834 $ 1,565,000 $ 1,695,417 Convertible debenture issued in August 2016 $ 200,000 $ 177,031 $ - $ - Convertible debenture issued in September 2016 $ 100,000 $ 88,650 $ - $ - Convertible debenture issued in November 2016 $ 200,000 $ 177,031 $ - $ -

Convertible Debentures (Tables)

Convertible Debentures (Tables)	6 Months Ended
	Dec. 31, 2016
Debt Disclosure [Abstract]
Schedule of Convertible Debentures	The following table sets forth activity associated with the convertible debentures: December 31, 2016 June 30, 2016 (unaudited) Convertible debentures issued in September 2014 $ 25,050 $ 25,050 Convertible debentures issued in January 2015 500,000 500,000 Convertible debentures issued in April - June 2016 1,565,000 1,565,000 Convertible debenture issued in August 2016 200,000 - Convertible debenture issued in September 2016 100,000 - Convertible debenture issued in October 2016 50,000 - Convertible debenture issued in November 2016 200,000 - 2,640,050 2,090,050 Less: amount converted to shares (150,000 ) - Total convertible debentures outstanding 2,490,050 2,090,050 Less: unamortized discount 406,577 527,350 Less: debt issuance costs 84,013 115,342 1,999,460 1,447,358 Less: current portion 85,042 407,702 Total convertible debentures, net of current portion $ 1,914,418 $ 1,039,656

Equity Transactions (Tables)

Equity Transactions (Tables)	6 Months Ended
	Dec. 31, 2016
Equity [Abstract]
Summary of Activity of Company's Stock Warrants	A summary of activity of the Company’s stock warrants for the six months ended December 31, 2016 is presented below: Weighted Weighted Average Weighted Average Remaining Average Exercise Number of Contractual Grant Date Price Warrants Term in Years Fair Value Balance as of June 30, 2016 $ 0.11 39,262,305 $ 0.15 Expired 0.18 (555,555 ) 0.14 Granted 0.17 4,458,034 0.09 Exercised 0.06 (11,250,000 ) 0.15 Cancelled - - - Balance as of December 31, 2016 $ 0.13 31,914,784 2.76 $ 0.14 Vested and exercisable as of December 31, 2016 $ 0.13 31,914,784 2.76 $ 0.14

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	6 Months Ended
	Dec. 31, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule of Valuation Assumptions Used to Estimate Fair Value of Stock Options	The following assumptions were used for the periods indicated: Six Months Ended December 31, 2016 2015 Expected volatility 140.73 % 147.62 % Expected dividend yield - - Risk-free interest rates 1.25 % 1.49 % Expected term (in years) 5.0 5.0
Summary of Award Activity Under Stock Option Plans	A summary of the activity of the Company’s stock options for the six months ended December 31, 2016 is presented below: Weighted Weighted Weighted Average Average Average Number of Remaining Optioned Aggregate Exercise Optioned Contractual Grant Date Intrinsic Price Shares Term in Years Fair Value Value Balance as of June 30, 2016 $ 0.08 75,375,248 $ 0.11 $ 3,771,601 Expired - - - Granted 0.12 2,500,000 0.10 Exercised - - - Cancelled 0.13 (3,100,000 ) - Balance as of December 31, 2016 $ 0.08 74,775,248 5.11 $ 0.11 $ 734,591 Vested and exercisable as of December 31, 2016 $ 0.07 64,908,580 4.45 $ 0.11 $ 1,095,591
Summary of Award Activity Under Restricted Stock Plans	A summary of the activity of the Company’s restricted stock awards for the six months ended December 31, 2016 is presented below: Number of Nonvested, Weighted Non-issued Average Restricted Grant Date Share Awards Fair Value Nonvested, nonissued restricted shares outstanding at June 30, 2016 1,000,000 $ 0.42 Granted - - Vested (500,000 ) 0.42 Forfeited - - Nonvested, nonissued restricted shares outstanding at December 31, 2016 500,000 $ 0.42

Loss Per Share (Tables)

Loss Per Share (Tables)	6 Months Ended
	Dec. 31, 2016
LOSS PER COMMON SHARE
Schedule of Computation of Basic and Diluted Loss Per Share	The following table sets forth the computation of basic and diluted loss per share: Three Months Ended Six Months Ended December 31, December 31, 2016 2015 2016 2015 (unaudited) Net loss $ (2,207,519 ) $ (2,519,658 ) $ (3,784,149 ) $ (3,386,607) Weighted average common shares outstanding: Basic and diluted 334,497,865 318,834,426 329,764,251 313,323,270 Basic and diluted loss per share $ (0.01 ) $ (0.01 ) $ (0.01 ) $ (0.01 )

Supplemental Cash Flow Inform30

Supplemental Cash Flow Information (Tables)	6 Months Ended
	Dec. 31, 2016
Supplemental Cash Flow Elements [Abstract]
Schedule of Supplemental Cash Flow Information	The following is supplemental cash flow information: Six Months Ended December 31 2016 2015 (unaudited) Cash paid for interest $ 292 $ 20,055 Cash paid for income taxes $ - $ - The following is supplemental disclosure of non-cash investing and financing activities: Six Months Ended December 31, 2016 2015 (unaudited) Allocated value of common stock and warrants issued with convertible debentures and promissory notes $ 179,084 $ - Prepaid expense paid in shares of common stock $ 19,536 $ 161,285 Financing of prepaid insurance $ 7,407 $ - Stock warrants issued for conversion of accrued salaries $ - $ 409,667 Cancellation of shares $ 195 $ - Stock issued for interest payments $ 4,284 $ - Conversion of debentures into common stock $ 150,000 $ -

Property and Equipment (Details

Property and Equipment (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 23,937	$ 21,591	$ 46,952	$ 42,000

Property and Equipment - Schedu

Property and Equipment - Schedule of Property and Equipment (Details) - USD ($)	Dec. 31, 2016	Jun. 30, 2016
Property and equipment gross	$ 957,687	$ 924,816
Less: accumulated depreciation	197,094	150,142
Total property and equipment, net	760,593	774,674
Furniture and Fixtures [Member]
Property and equipment gross	1,625	1,625
Computers and Software [Member]
Property and equipment gross	11,447	11,447
Machinery and Equipment [Member]
Property and equipment gross	$ 944,615	$ 911,744

Licenses and Patents (Details N

Licenses and Patents (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Finite-Lived Intangible Assets, Net [Abstract]
Amortization expense	$ 9,637	$ 9,637	$ 19,274	$ 19,274

Licenses and Patents - Schedule

Licenses and Patents - Schedule of Licenses and Patents (Details) - USD ($)	Dec. 31, 2016	Jun. 30, 2016
Licenses and patents, gross	$ 192,743	$ 192,743
Less: accumulated amortization	94,530	75,256
Total licenses and patents, net	98,213	117,487
William Marsh Rice University [Member]
Licenses and patents, gross	40,000	40,000
University of Arizona [Member]
Licenses and patents, gross	15,000	15,000
Bayer Acquired Patents [Member]
Licenses and patents, gross	$ 137,743	$ 137,743

Fair Value of Financial Instr35

Fair Value of Financial Instruments - Schedule of Fair Value of Convertible Debentures (Details) - Level 2 [Member] - USD ($)	Dec. 31, 2016	Jun. 30, 2016
Convertible Debentures Issued in September 2014 [Member] | Carrying Value [Member]
Convertible debentures	$ 25,050	$ 25,050
Convertible Debentures Issued in September 2014 [Member] | Fair Value [Member]
Convertible debentures	22,525	21,710
Convertible Debentures Issued in January 2015 [Member] | Carrying Value [Member]
Convertible debentures	500,000	500,000
Convertible Debentures Issued in January 2015 [Member] | Fair Value [Member]
Convertible debentures	750,000	1,083,333
Convertible Debentures Issued in April - June 2016 [Member] | Carrying Value [Member]
Convertible debentures	1,465,000	1,565,000
Convertible Debentures Issued in April - June 2016 [Member] | Fair Value [Member]
Convertible debentures	1,220,834	1,695,417
Convertible Debenture Issued in August 2016 [Member] | Carrying Value [Member]
Convertible debentures	200,000
Convertible Debenture Issued in August 2016 [Member] | Fair Value [Member]
Convertible debentures	177,031
Convertible Debenture Issued in September 2016 [Member] | Carrying Value [Member]
Convertible debentures	100,000
Convertible Debenture Issued in September 2016 [Member] | Carrying Value [Member]
Convertible debentures
Convertible Debenture Issued in September 2016 [Member] | Fair Value [Member]
Convertible debentures	88,650
Convertible Debenture Issued in November 2016 [Member] | Carrying Value [Member]
Convertible debentures	200,000
Convertible Debenture Issued in November 2016 [Member] | Fair Value [Member]
Convertible debentures	$ 177,031

Convertible Debentures (Details

Convertible Debentures (Details Narrative) - USD ($)	Jan. 15, 2015	Sep. 16, 2014	Nov. 30, 2016	Oct. 31, 2016	Aug. 31, 2016	Dec. 31, 2016	Jun. 30, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Debt Instrument [Line Items]
Debt instrument principal amount						$ 2,640,050	$ 2,090,050		$ 2,640,050
Convertible promissory note						1,999,460	$ 1,447,358		1,999,460
Proceeds from issuance of convertible debenture									$ 550,000
Common stock issued for warrant exercises, shares									2,500,000
Accretion of debt discount						$ (186,569)		$ (43,037)	$ (299,857)	(85,224)
Common stock, par value						$ 0.001	$ 0.001		$ 0.001
Fair value of warrants									$ 821,979
Beneficial conversion expense						$ 24,381			94,298
Amortization expense						15,821		0	31,329	0
September 2014 Convertible Debenture [Member]
Debt Instrument [Line Items]
Debt instrument principal amount		$ 500,050
Debt interest rate		6.00%
Debenture, conversion price		$ 0.15
Percentage of strike price per share		$ 0.30
Warrant term		5 years
Maturity date description		September 16, 2019 and October 30, 2019
Interest expense						384		384	768	768
Notes payable						25,050			25,050
Unregistered and restricted convertible debenture fair value						25,050			25,050
January 2015 Convertible Debenture [Member]
Debt Instrument [Line Items]
Debt interest rate	8.00%
Debenture, conversion price	$ 0.06
Interest expense						10,082		10,082	20,164	20,164
Notes payable						500,000			$ 500,000
Proceeds from issuance of convertible debenture	$ 500,000
Debt instruments maturity date	Jan. 15, 2017
Common stock issued for warrant exercises, shares									6,250,000
Allocated value of warrants related to debenture	$ 348,105
Accretion of debt discount						$ 46,609		43,037	$ 92,298	85,224
Warrants exercise price per share	$ 0.06
January 2015 Convertible Debenture [Member] | January 2017 [Member]
Debt Instrument [Line Items]
Warrants converted into common stock						6,250,000			6,250,000
Proceeds from issuance of warrants									$ 375,000
January 2015 Convertible Debenture [Member] | October 10, 2016 [Member]
Debt Instrument [Line Items]
Debt instruments maturity date									Jan. 15, 2018
April - June and October 2016 Convertible Debentures [Member]
Debt Instrument [Line Items]
Debt interest rate							8.00%
Interest expense						$ 35,105		0	$ 68,789	0
Warrants converted into common stock							4,166
Notes payable						1,665,000			1,665,000
Accretion of debt discount						100,349		0	162,454	0
Common stock, par value							$ 0.001
Sale of stock transaction during period				$ 50,000	$ 200,000		$ 1,565,000
Sale of stock transaction during period, shares					200		1,565
Warrants exercise price per share							$ 0.15
Fair value of warrants									566,778
Beneficial conversion expense						4,897		0	45,291	0
April - June and October 2016 Convertible Debentures [Member] | Unsecured Convertible Promissory Note [Member]
Debt Instrument [Line Items]
Debt instrument principal amount							$ 1,000
Warrants exercise price per share							$ 0.12
September 2016 Convertible Promissory Note [Member]
Debt Instrument [Line Items]
Debt instrument principal amount						$ 100,000			$ 100,000
Debt interest rate						8.00%			8.00%
Debenture, conversion price						$ 0.12			$ 0.12
Interest expense						$ 3,653		0	$ 7,258	0
Notes payable						100,000			100,000
Convertible promissory note						150,000			$ 150,000
Debt instruments maturity date									May 15, 2017
Common stock issued for warrant exercises, shares									250,000
Accretion of debt discount						$ 10,959		0	$ 14,564	0
Warrants exercise price per share						$ 0.12			$ 0.12
Beneficial conversion expense						$ 0		0	$ 29,523	0
Unregistered and restricted shares issued for conversion of debentures									200,000
Unregistered and restricted convertible debenture fair value						100,000			$ 100,000
Proceeds from issuance of warrants									29,523
November 2016 Convertible Promissory Notes [Member] | Securities Purchase Agreement [Member]
Debt Instrument [Line Items]
Maturity date description			The promissory note has a term of twenty-four months maturing on November 7, 2017 and stipulates a one-time interest charge of eight percent (8%) shall be applied on the issuance date to the principal.
Proceeds from issuance of convertible debenture			$ 200,000
Debt instruments maturity date			Nov. 7, 2017
Proceeds from issuance of warrants			$ 52,817
November 2016 Convertible Promissory Notes [Member]
Debt Instrument [Line Items]
Notes payable						200,000			200,000
November 2016 Convertible Promissory Notes [Member] | Securities Purchase Agreement [Member]
Debt Instrument [Line Items]
Debt instrument principal amount			$ 200,000
Debt interest rate			8.00%
Debenture, conversion price			$ 0.12
Interest expense						2,400		0	2,400	0
Accretion of debt discount						4,807		0	4,807	0
Beneficial conversion expense						$ 19,484		$ 0	$ 19,484	$ 0

Convertible Debentures - Schedu

Convertible Debentures - Schedule of Convertible Debentures (Details) - USD ($)	Dec. 31, 2016	Jun. 30, 2016
Debt Instrument [Line Items]
Convertible debenture	$ 2,640,050	$ 2,090,050
Less: amount converted to shares	(150,000)
Total convertible debentures outstanding	2,490,050	2,090,050
Less: unamortized discount	406,577	527,350
Less: debt issuance costs	84,013	115,342
Total convertible debt	1,999,460	1,447,358
Less: current portion	85,042	407,702
Total convertible debentures, net of current portion	1,914,418	1,039,656
Convertible Debentures Issued in September 2014 [Member]
Debt Instrument [Line Items]
Convertible debenture	25,050	25,050
Convertible Debentures Issued in January 2015 [Member]
Debt Instrument [Line Items]
Convertible debenture	500,000	500,000
Convertible Debentures Issued in April - June 2016 [Member]
Debt Instrument [Line Items]
Convertible debenture	1,565,000	1,565,000
Convertible Debenture Issued in August 2016 [Member]
Debt Instrument [Line Items]
Convertible debenture	200,000
Convertible Debenture Issued in September 2016 [Member]
Debt Instrument [Line Items]
Convertible debenture	100,000
Convertible Debenture Issued in October 2016 [Member]
Debt Instrument [Line Items]
Convertible debenture	50,000
Convertible Debentures Issued in November 2016 [Member]
Debt Instrument [Line Items]
Convertible debenture	$ 200,000

Notes Payable (Details Narrativ

Notes Payable (Details Narrative) - USD ($)	1 Months Ended		3 Months Ended		6 Months Ended
	Sep. 30, 2016	Aug. 31, 2016	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Accretion of debt discount			$ 186,569	$ 43,037	$ 299,857	$ 85,224
Proceeds from notes payable					100,000
Promissory Note [Member]
Unsecured promissory	$ 100,000
Debt interest rate	0.00%
Issuance of warrants to common stock	416,667
Warrants exercisable price per share	$ 0.15
Debt instruments maturity date description	The note was due October 13, 2016 and was repaid on October 11, 2016.
Proceeds from issuance of warrants	$ 26,454
Accretion of debt discount			24,564	$ 0	26,454	$ 0
Notes payable			0		0
Note Payable Insurance [Member]
Debt interest rate		4.87%
Proceeds from notes payable		$ 13,959
Debt instruments maturity date		May 5, 2017
Note Payable Insurance Two [Member]
Notes payable			$ 7,818		$ 7,818

Equity Transactions (Details Na

Equity Transactions (Details Narrative)	6 Months Ended
	Dec. 31, 2016USD ($)$ / sharesshares
Number of common stock shares issued for services, shares	1,750,000
Number of common stock shares issued for services | $	$ 175,000
Common stock issued for debenture interest | $	$ 4,285
Allocated value of common stock issued for debenture conversion, shares	200,000
Allocated value of common stock issued for debenture conversion | $	$ 179,084
Minimum [Member] | January 2017 to November 2021 [Member]
Warrants exercise price per share | $ / shares	$ 0.04
Maximum [Member] | January 2017 to November 2021 [Member]
Warrants exercise price per share | $ / shares	$ 0.30
Common Stock [Member]
Common stock issued for debenture interest, shares	35,708
Common stock issued for debenture interest | $	$ 4,285
Allocated value of common stock issued for debenture conversion, shares	1,250,000
Allocated value of common stock issued for debenture conversion | $	$ 150,000
Common stock issued for warrants exercised, shares	8,750,000
Number of shares issued with cashless exercise price	2,500,000
Share cancellations, shares	194,059
Consultants [Member]
Number of common stock shares issued for services, shares	250,000
Number of common stock shares issued for services | $	$ 25,000

Equity Transactions - Summary o

Equity Transactions - Summary of Activity of Company's Stock Warrants (Details) - Warrant [Member]	6 Months Ended
	Dec. 31, 2016$ / sharesshares
Weighted Average Exercise Price Beginning Balance	$ 0.11
Weighted Average Exercise Price Expired	0.18
Weighted Average Exercise Price Granted	0.17
Weighted Average Exercise Price Exercised	0.06
Weighted Average Exercise Price Cancelled
Weighted Average Exercise Price Ending Balance	0.13
Weighted Average Exercise Price Vested and exercisable	$ 0.13
Number of Warrants Beginning Balance | shares	39,262,305
Number of Warrants Expired | shares	(555,555)
Number of Warrants Granted | shares	4,458,034
Number of Warrants Exercised	$ (11,250,000)
Number of Warrants Cancelled | shares
Number of Warrants Ending Balance | shares	31,914,784
Number of Warrants Vested and exercisable | shares	31,914,784
Weighted Average Remaining Contractual Term in Years	2 years 9 months 4 days
Weighted Average Remaining Contractual Term in Years Vested and exercisable	2 years 9 months 4 days
Weighted Average Grant Date Fair Value Beginning Balance	$ 0.15
Weighted Average Grant Date Fair Value Expired	0.14
Weighted Average Grant Date Fair Value Granted	0.09
Weighted Average Grant Date Fair Value Exercised	0.15
Weighted Average Grant Date Fair Value Cancelled
Weighted Average Grant Date Fair Value Ending Balance	0.14
Weighted Average Grant Date Fair Value Vested and exercisable	$ 0.14

Stock-Based Compensation (Detai

Stock-Based Compensation (Details Narrative) - USD ($)

1 Months Ended

3 Months Ended

6 Months Ended

12 Months Ended

Mar. 31, 2012

Dec. 31, 2016

Sep. 30, 2016

Dec. 31, 2015

Dec. 31, 2016

Dec. 31, 2015

Jun. 30, 2016

Feb. 17, 2016

Mar. 31, 2013

Jan. 31, 2013

Jan. 31, 2010

Oct. 31, 2009

Stock Options [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Options granted, shares

3,500,000

6,000,000

Options cancelled, shares

3,000,000

Options term

5 years

10 years

Compensation expense

$ 568,599

$ 1,162,431

$ 740,789

$ 1,340,905

Nonvested stock option awards, shares

9,866,668

9,866,668

Cost of nonvested stock option awards not yet recognized

$ 721,253

$ 721,253

Period of nonvested stock option awards not yet recognized for recognition

2 years 9 months

Stock Options [Member] | Officers And Employees [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Number of shares restricted for exercise under stock option plan and no common stock reserved

57,670,933

Stock Options [Member] | Minimum [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Historical forfeiture rates

14.00%

Option expiration year

2017-03

Stock option exercise price per share

$ 0.04

$ 0.04

Stock Options [Member] | Maximum [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Historical forfeiture rates

17.00%

Option expiration year

2026-06

Stock option exercise price per share

$ 0.17

$ 0.17

Stock Options [Member] | Stock Option Plan Authorized 2009 [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Number of common stock authorized, shares

10,000,000

7,500,000

Options granted, shares

9,200,000

9,200,000

Options cancelled, shares

250,000

250,000

Stock Options [Member] | Stock Option Plan Authorized 2009 [Member] | Minimum [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Options term

5 years

Stock Options [Member] | Stock Option Plan Authorized 2009 [Member] | Maximum [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Options term

10 years

Stock Options [Member] | Stock Option Plan Authorized 2013 [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Number of common stock authorized, shares

60,000,000

20,000,000

Options granted, shares

72,653,473

72,653,473

Options cancelled, shares

12,803,225

12,803,225

Options exercised, shares

3,325,000

3,325,000

Stock Options [Member] | Stock Option Plan Authorized 2013 [Member] | Minimum [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Options term

5 years

Stock Options [Member] | Stock Option Plan Authorized 2013 [Member] | Maximum [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Options term

10 years

Stock Options [Member] | Employee Benefit And Consulting Services Compensation Plan [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Number of common stock authorized, shares

15,000,000

Options granted, shares

2,800,000

2,800,000

Options term

5 years

Restricted Stock [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Compensation expense

$ 52,931

$ 87,932

$ 105,863

$ 140,863

Cost of nonvested stock option awards not yet recognized

$ 112,192

$ 112,192

Option vesting period

3 years

Stock-Based Compensation - Sche

Stock-Based Compensation - Schedule of Valuation Assumptions Used to Estimate Fair Value of Stock Options (Details)	6 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Expected volatility	140.73%	147.62%
Expected dividend yield
Risk-free interest rates	1.25%	1.49%
Expected term (in years)	5 years	5 years

Stock-Based Compensation - Summ

Stock-Based Compensation - Summary of Award Activity Under Stock Option Plans (Details)	6 Months Ended
	Dec. 31, 2016USD ($)$ / sharesshares
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Weighted Average Exercise Price Balance	$ 0.08
Weighted Average Exercise Price Expired
Weighted Average Exercise Price Granted	0.12
Weighted Average Exercise Price Exercised
Weighted Average Exercise Price Cancelled	0.13
Weighted Average Exercise Price Balance	0.08
Weighted Average Exercise Price Vested and exercisable	$ 0.07
Number of Optioned Shares Balance | shares	75,375,248
Number of Optioned Shares Expired | shares
Number of Optioned Shares Granted | shares	2,500,000
Number of Optioned Shares Exercised | shares
Number of Optioned Shares Cancelled | shares	(3,100,000)
Number of Optioned Shares Balance | shares	74,775,248
Number of Optioned Shares Vested and exercisable | shares	64,908,580
Weighted Average Remaining Contractual Term in Years Balance	5 years 1 month 10 days
Weighted Average Remaining Contractual Term in Years Vested and exercisable	4 years 5 months 12 days
Weighted Average Optioned Grant Date Fair Value Balance	$ 0.11
Weighted Average Optioned Grant Date Fair Value Expired
Weighted Average Optioned Grant Date Fair Value Granted	0.10
Weighted Average Optioned Grant Date Fair Value Exercised
Weighted Average Optioned Grant Date Fair Value Cancelled
Weighted Average Optioned Grant Date Fair Value Balance	0.11
Weighted Average Optioned Grant Date Fair Value Vested and exercisable	$ 0.11
Aggregate Intrinsic Value Aggregate intrinsic value Balance | $	$ 3,771,601
Aggregate Intrinsic Value Aggregate intrinsic value Balance | $	734,591
Aggregate Intrinsic Value Vested and exercisable | $	$ 1,095,591

Stock-Based Compensation - Su44

Stock-Based Compensation - Summary of Award Activity Under Restricted Stock Plans (Details) - Restricted Stock [Member]	6 Months Ended
	Dec. 31, 2016$ / sharesshares
Number of Nonvested Non-issued Restricted Shares Awards, Beginning Balance | shares	1,000,000
Number of Nonvested Non-issued Restricted Shares Awards, Granted | shares
Number of Nonvested Non-issued Restricted Shares Awards, Vested | shares	(500,000)
Number of Nonvested Non-issued Restricted Shares Awards, Forfeited | shares
Number of Nonvested Non-issued Restricted Shares Awards, Ending Balance | shares	500,000
Weighted Average Grant Date Fair Value, Beginning Balance | $ / shares	$ 0.42
Weighted Average Grant Date Fair Value, Granted | $ / shares
Weighted Average Grant Date Fair Value, Vested | $ / shares	0.42
Weighted Average Grant Date Fair Value, Forfeited | $ / shares
Weighted Average Grant Date Fair Value, Ending Balance | $ / shares	$ 0.42

Loss Per Share (Details Narrati

Loss Per Share (Details Narrative) - shares	3 Months Ended		6 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Stock Options [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Common stock excluded from diluted EPS	74,775,248	62,625,248	74,775,248	62,625,248
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Common stock excluded from diluted EPS	31,914,784	36,994,557	31,914,784	36,994,557

Loss Per Share - Schedule of Co

Loss Per Share - Schedule of Computation of Basic and Diluted Loss Per Share (Details) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
LOSS PER COMMON SHARE
Net loss	$ (2,207,519)	$ (2,519,658)	$ (3,784,149)	$ (3,386,607)
Weighted average common shares outstanding: Basic and diluted	334,497,865	318,834,426	329,764,251	313,323,270
Basic and diluted loss per share	$ (0.01)	$ (0.01)	$ (0.01)	$ (0.01)

Commitments and Contingencies (

Commitments and Contingencies (Details Narrative)	6 Months Ended
	Dec. 31, 2016USD ($)
William Marsh Rice University [Member] | License Agreements [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Royalties payable due in first installment period	$ 117,000
Royalties payable due in second installment period	292,500
Royalties, future minimum payments due on each january 1st thereafter	$ 585,000
William Marsh Rice University [Member] | Quantum Dots [Member] | License Agreements [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Percentage of adjusted gross sales	7.50%
Texas State University [Member] | Service Agreement [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Period of termination notice for the memorandum of understanding	30 days
Solterra Renewable Technologies Inc [Member] | William Marsh Rice University [Member] | License Agreements [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Royalties payable due in first installment period	$ 100,000
Royalties payable due in second installment period	356,250
Royalties payable due in third installment period	1,453,500
Royalties, future minimum payments due on each january 1st thereafter	$ 3,153,600
Solterra Renewable Technologies Inc [Member] | William Marsh Rice University [Member] | Photovoltaic Cells [Member] | Minimum [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Percentage of adjusted gross sales	2.00%
Solterra Renewable Technologies Inc [Member] | William Marsh Rice University [Member] | Photovoltaic Cells [Member] | Maximum [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Percentage of adjusted gross sales	4.00%
Solterra Renewable Technologies Inc [Member] | William Marsh Rice University [Member] | Quantum Dots [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Percentage of adjusted gross sales	7.50%
Solterra Renewable Technologies Inc [Member] | University of Arizona [Member] | License Agreements [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Royalties payable due in first installment period	$ 50,000
Royalties payable due in second installment period	125,000
Royalties, future minimum payments due on each january 1st thereafter	$ 200,000
Solterra Renewable Technologies Inc [Member] | University of Arizona [Member] | Non Display Electronic Component Applications [Member] | License Agreements [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Percentage of adjusted gross sales	2.00%
Solterra Renewable Technologies Inc [Member] | University of Arizona [Member] | Printed Electronic Displays [Member] | License Agreements [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Percentage of adjusted gross sales	2.50%

Income Tax (Details Narrative)

Income Tax (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Net operating loss carryforwards	$ 28,230,000		$ 28,230,000
Net operating loss carryforwards expiration year			2,029
Ownership change limitation amount			$ 750,000
Income tax rate	0.00%	0.00%	0.00%	0.00%
Minimum [Member]
Net operating loss carryforwards	$ 27,480,000		$ 27,480,000
U.S [Member]
Net operating loss carryforwards	$ 25,560,000		$ 25,560,000

Supplemental Cash Flow Inform49

Supplemental Cash Flow Information - Schedule of Supplemental Cash Flow Information (Details) - USD ($)	6 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Supplemental Cash Flow Elements [Abstract]
Cash paid for interest	$ 292	$ 20,055
Cash paid for income taxes
Allocated value of common stock and warrants issued with convertible debentures and promissory notes	179,084
Prepaid expense paid in shares of common stock	19,536	161,285
Financing of prepaid insurance	7,407
Stock warrants issued for conversion of accured salaries		409,667
Cancellation of shares	195
Stock issued for interest payments	4,284
Conversion of debentures into common stock	$ 150,000

Transactions with Affiliated 50

Transactions with Affiliated Parties (Details Narrative) - USD ($)	6 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Sep. 30, 2016
Related Party Transaction [Line Items]
Proceeds from convertible debt	$ 550,000
Family Members of Key Executive [Member]
Related Party Transaction [Line Items]
Proceeds from convertible debt	$ 200,000
Chief Financial Officer [Member]
Related Party Transaction [Line Items]
Due to related party			$ 100,000

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - USD ($)	Feb. 02, 2017	Jan. 17, 2017	Feb. 28, 2017	Jan. 31, 2017	Dec. 31, 2016	Jan. 30, 2017	Jan. 12, 2017	Jun. 30, 2016
Debt instrument face amount					$ 2,640,050			$ 2,090,050
Common stock issued for services, shares					1,750,000
Common stock issued for services					$ 175,000
Subsequent Event [Member] | Consulting Agreement [Member]
Number of common stock shares issued			2,000,000	1,000,000
Subsequent Event [Member] | Line of Credit Agreement [Member]
Number of common stock shares issued			1,466,666
Line of credit maximum borrowing			$ 500,000
Subsequent Event [Member] | Securities Purchase Agreement [Member]
Number of common stock shares issued			200,000
Subsequent Event [Member] | Two Consulting Agreement [Member]
Number of common stock shares issued			5,125,000
Subsequent Event [Member] | Craig Lindberg [Member]
Payment unpaid wages					$ 10,000
Subsequent Event [Member] | Craig Lindberg [Member] | January and February, 2017 [Member]
Payment unpaid wages	$ 20,000
Subsequent Event [Member] | Mr. Lindberg's [Member]
Number of stock options and warrants vested, shares	11,729,157
Payment unpaid wages	$ 14,543
Subsequent Event [Member] | E. Jamie Schloss [Member]
Initial salary per month	$ 4,600
Subsequent Event [Member] | San Diego Torrey Hills Capital, Inc [Member]
Common stock issued for services, shares		1,000,000
Common stock issued for services		$ 70,000
Subsequent Event [Member] | Guanghui Technology Group [Member]
Investment owned, at cost						$ 21,800,000
Ownership interest rate						25.00%
Profit distributions, percentage						50.00%
Subsequent Event [Member] | Unsecured Convertible Promissory Notes [Member]
Debt instrument face amount							$ 110,000
Warrants to purchase common stock							458,260
Shares Issued Price Per Share							$ 0.15